Roberto Caporali to Biological Products
This is a "connection" page, showing publications Roberto Caporali has written about Biological Products.
Connection Strength
0.500
-
20 years of experience with tumour necrosis factor inhibitors: what have we learned? Rheumatology (Oxford). 2018 10 01; 57(57 Suppl 7):vii5-vii10.
Score: 0.258
-
Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry. Int J Rheum Dis. 2018 Feb; 21(2):422-430.
Score: 0.242